Action INTI INHIBITOR THERAPEUTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Inhibitor Therapeutics, Inc.

Actions

INTI

US45720M1053

Marché Fermé - OTC Markets
Autres places de cotation
 16:39:25 20/06/2024 		Varia. 5j. Varia. 1 janv.
0,079 USD -0,05% Graphique intraday de Inhibitor Therapeutics, Inc. -.--% -14,13%
13/05 Inhibitor Therapeutics, Inc. annonce ses résultats pour le premier trimestre se terminant le 31 mars 2024 CI
29/03 Inhibitor Therapeutics, Inc. annonce ses résultats pour l'année complète se terminant le 31 décembre 2023 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board
AQ
Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University
PR
INHIBITOR THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
INHIBITOR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Inhibitor Therapeutics : NOTICE OF PENDENCY OF DERIVATIVE AND CLASS ACTIONS, PROPOSED SETTLEMENT AND SETTLEMENT HEARING - Form 8-K
PU
INHIBITOR THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
INHIBITOR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
INHIBITOR THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
INHIBITOR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action INTI
  4. Actualités Inhibitor Therapeutics, Inc.
  5. Communiqués